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HIV PREVENTION: PROGRESS TO DATE
The science is clear: HIV prevention can and does save lives.  Scores of scientific  
studies have shown that well-designed prevention programs can significantly reduce HIV risk1-6; HIV transmission  
rates have dropped dramatically; and prevention efforts have contributed to significant declines in new infections in 
multiple populations over time.  In addition, more Americans are being tested for HIV than ever before.  While the  
HIV crisis in the United States is far from over, substantial progress has been made in combatting the HIV epidemic  
to date.  This document highlights several indicators of success, including the latest data on trends in new HIV  
infections, HIV transmission rates, HIV testing rates, and models estimating the lives and resources saved through  
U.S. prevention efforts.
Trends in New HIV Infections
The nation’s investment in HIV prevention has contrib-
uted to dramatic reductions in the annual number of 
new infections since the peak of the epidemic in the 
mid-1980s, and an overall stabilization of new infections 
since the mid-1990s (from roughly 130,000 new infec-
tions to approximately 50,000 annually).7,8  While new 
infections per year continue at too high a level,  this  
stabilization is in itself a sign of progress.  With contin-
ued increases in the number of people living with HIV 
thanks to effective HIV medications, there are more  
opportunities for HIV transmission than ever before.9  
Yet, the annual number of new infections has not  
increased, indicating that HIV testing, prevention, and 
treatment programs are effectively reducing the rate of 
transmission overall. Declines in new infections have  
also been documented in several key populations over 
time, underscoring the impact and importance of  
concentrated prevention efforts:
• HIV -infected infants:  In 1995, CDC began recom-
mending routine HIV screening of pregnant women, 
following research findings that HIV medications signifi-
cantly reduce the risk of transmission from HIV-infected 
pregnant women to their infants.  Since that time, test-
ing of pregnant women and treatment for those who 
are infected have resulted in a dramatic decline in the 
number of babies born with HIV, from a peak of 1,650  
in 1991 to fewer than 200 per year today.10 
 
•  Individuals who inject drugs:  Studies show that  
comprehensive prevention and drug treatment  
programs, including needle exchange, have  
dramatically cut the number of new HIV infections 
among injecting drug users (IDUs).11-13  In fact, HIV 
infections among IDUs have dropped from a peak of 
nearly 35,000 infections annually in the late 1980s to 
just 3,900 new infections in 2010.7,8  
• Heter osexuals:  The number of new infections among 
heterosexuals in the United States increased during the 
1980s and fluctuated somewhat throughout the 1990s, 
reaching 21,900 per year at its peak.7  Since then,  
new infections declined and have remained relatively 
stable in recent years, with 12,100 infections occurring 
in 2010.7,8
Gay and bisexual men
In addition to working to build on the successes in these 
populations, it is also critical to accelerate progress in 
combatting the current HIV crisis among gay and bi-
sexual men.  Community and public health prevention 
efforts led to dramatic success in this population in the 
early years of the epidemic. After new HIV infections 
among men who have sex with men (MSM) peaked in 
the mid-1980s at more than 75,000 new infections a year, 
the number of new infections plummeted to less than 
18,000 per year by the early 1990s.  Unfortunately, after 
years of steady progress, new infections again began to 
rise among MSM throughout the 1990s.7  While in recent 
years, prevention efforts may have helped stabilize infec-
tions, they are occurring at far too high a level (29,800 per 
year.)8  Additionally, young MSM are the only risk group 
in which new infections are increasing.  This underscores 
the need to sustain and re-invigorate prevention efforts 
for gay and bisexual men of every race and to ensure that 
each generation is effectively reached.
Indicators of Prevention  
Success
• Trends in new HIV infections
• HIV transmission rates
• HIV testing rates
• Models of the impact of prevention 
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New HIV Infections by Transmission Category, 1980 – 2010
Estimates use back calculation methodology for 1980-2006, original incidence surveillance methodology for 2006, and updated 
incidence surveillance methodology for 2007-2010.
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Another useful measure of the impact of prevention and 
treatment efforts among individuals living with HIV is the 
estimated rate of HIV transmission – which indicates the 
likelihood that an HIV-infected individual will transmit the 
virus to others.  CDC estimates that that there are only 
four transmissions per year for every 100 people living 
with HIV in the United States, which means that the vast 
majority (at least 95 percent) of people living with HIV do 
not transmit the virus to anyone else.14  This represents 
an 89 percent decline in the transmission rate since the 
mid-1980s, reflecting the combined impact of testing, 
prevention counseling, and treatment efforts targeted to 
those living with HIV infection.15  
HIV Testing Rates
More Americans than ever before are getting tested for 
HIV.  According to a recent CDC analysis, the proportion 
of adults who had ever been tested for HIV increased 
from 37 percent in 2000 to 45 percent in 2010.16  
Increasing the number of people tested is a critical com-
ponent of the nation’s HIV prevention efforts, especially 
in light of data showing that half of new infections in the 
United States are transmitted by people who are unaware 
of their infection.17  Linkage to care following a diagno-
sis allows people with HIV to receive treatment that can 
protect their health, extend their lives, and greatly reduce 
the likelihood of transmitting HIV to others.  Additionally, 
research shows that when people learn they are infected, 
they take steps to protect their own health and prevent 
HIV transmission to others.18  
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Each calendar year should consume the same 
amount of space on the horizontal axis. (Except for 
2006, which will have to appear twice). 
 
So, if a year = 1 inch, the columns representing 
1980-81, 82-83, 84-85, 86-87 would each be 2 
inches wide.  The columns representing 1988-1990, 
91-93, 96-96, 97-99, 2000-02 would each be 3 
inches wide.  The columns representing 2003-2006 
would be 4 inches wide.  The columns representing 
2006, 2007, 2008, 2009 and 2010 would each be 1 
inch wide.
 
Obviously having a year = an inch is too big for this 
piece of paper, but that’s the idea.
 
Also, for 1980-81, there were 400 infections/year 
among heterosexuals.  It’s tiny given the scale so 
may not really show up, but we need to at least 
include the space for the yellow column there (right 
now it’s skipped over).
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Models of the Impact of Prevention
Because it is difficult to measure what does not occur – 
the number of infections prevented, illnesses avoided, 
and lives saved – scientists have developed models to 
help quantify the overall impact of prevention.  Based 
on the trajectory of the epidemic before prevention 
programs were initiated, researchers can estimate the 
number of HIV infections that have been averted.   
These models suggest that more than 350,000 HIV  
infections have been avoided because of the nation’s  
HIV prevention efforts.19  
In addition to lives saved, HIV prevention has also  
generated substantial economic benefits.  For every  
HIV infection that is prevented, an estimated $360,000  
is saved in the cost of providing lifetime HIV treatment.  
It is estimated that HIV prevention efforts have averted 
more than $125 billion in medical costs since the  
beginning of the epidemic.19  
By building upon progress to date and maximizing the 
impact of the range of proven prevention tools now  
available, there is more hope than ever before of ending 
the HIV epidemic in the United States. 
Fighting HIV Among Heterosexual Women:  
Access Community Health Network
The Access Community Health Network (ACCESS), Chicago’s 
largest private provider of primary and preventive health care, 
uses surveillance data from the Chicago Department of  
Public Health to identify specific neighborhoods with high  
rates of HIV infection, particularly among African American 
women.  ACCESS reaches out to women in these communities 
with customized HIV counseling, testing, and linkage-to-care 
services using a number of targeted programs supported by 
CDC, including:
•  WiLLOW (Women Involved in Life Learning from Other  
Women), which helps HIV-positive women stay in  
medical care
•  CLEAR (Choosing Life: Empowerment! Action! Results!),  
a program of personalized counseling and care for women  
at greatest risk for HIV infection
•  CTR (HIV Counseling, Testing & Referral), which works  
directly with at-risk women to provide prevention information 
and testing 
ACCESS is able to scale up its intensive individual and  
small-group programs by training instructors to participate in 
multiple interventions and applying lessons learned in each  
program to all the others.  Program participants also expand  
the organization’s reach, helping to refer additional women 
through social networking.  These efforts allow ACCESS to 
deliver proven prevention tools widely – for example, providing 
HIV testing to nearly 20,000 individuals and distributing more 
than 60,000 condoms each year. 
CLEAR helps participants make healthy 
choices in all areas of their lives
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HIV Testing in Action: Washington, D.C.
Expanded HIV testing is helping Washington, D.C.’s HIV/AIDS, Hepatitis, STD, and 
TB Administration (HAHSTA) make encouraging progress in the fight against HIV 
in the nation’s capital.  With support from CDC, HAHSTA launched the Municipal 
Scale-up of HIV Screening program in 2006.  This initiative is expanding HIV test-
ing in a variety of health care settings and, increasingly, non-traditional settings, 
such as Low Income Benefits centers where families apply for economic assis-
tance and the Department of Motor Vehicles, where individuals can obtain an HIV 
test while waiting for a driver’s license.
HAHSTA encourages residents to seek HIV testing using a range of marketing 
channels and materials, including print ads, radio spots, billboards, and the DC-
TakesOnHIV.com website.  Since the program began, testing has increased by  
400 percent, from fewer than 30,000 tests in 2006 to 122,000 in 2011. 
HAHSTA also carefully examined its counseling and testing procedures to help 
ensure that people testing positive receive the care and treatment they need –  
and now successfully links three-quarters of people with HIV to care. 
Routine voluntary HIV testing 
is the standard of care in 
Washington, D.C.
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